A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy Volunteers

Trial Identifier: D7550C00005
Sponsor: AstraZeneca
Collaborator:
PAREXEL
NCTID:: NCT03420092
Start Date: February 2018
Primary Completion Date: April 2018
Study Completion Date: April 2018
Condition: Coronary Artery Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United Kingdom London, United Kingdom, HA1 3UJ